Kolexia
Teisseyre Maxime
Néphrologie
CHU Nice
Nice, France
46 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Glomérulonéphrite extra-membraneuse Syndrome néphrotique Maladies du rein COVID-19 Glomérulonéphrite Breakthrough Infections Maladies transmissibles Infections à coronavirus Insuffisance rénale chronique

Industries

AstraZeneca
4 collaboration(s)
Dernière en 2023
GSK
3 collaboration(s)
Dernière en 2023
PASCALEO
2 collaboration(s)
Dernière en 2023
Otsuka
1 collaboration(s)
Dernière en 2022

Dernières activités

SOURIS: Indication and Response to Immunosuppressive Treatment in Membranous Nephropathy : Role of Anti-mouse PLA2R1 ELISA
Essai Clinique (CHU Nice)   15 novembre 2023
Optimization of Rituximab Therapy in Adult Patients With PLA2R1-Associated Membranous Nephropathy With Artificial Intelligence.
Kidney international reports   03 novembre 2023
Both Humoral and Cellular Immune Responses to SARS-CoV-2 Are Essential to Prevent Infection: a Prospective Study in a Working Vaccinated Population from Southern France.
Journal of clinical immunology   22 août 2023
ALPHAGEM: Study of Immunological Activity After Personalized Immunomodulatory Therapy Regulating the Th17 Pathway in Patients With Membranous Nephropathy
Essai Clinique (CHU Nice)   04 juillet 2023
Drug-induced minimal change disease: Disproportionality analysis of the WHO safety database
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 12–14 June 2023, Limoges, France   07 juin 2023
Drug-induced membranous nephropathy: Disproportionality analysis of the WHO safety database
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 12–14 June 2023, Limoges, France   07 juin 2023
Risk Factors Associated with the Occurrence of Anti-rituximab Antibodies in Membranous Nephropathy.
Clinical journal of the American Society of Nephrology : CJASN   17 avril 2023
Breakthrough infections due to SARS-CoV-2 Delta variant: relation to humoral and cellular vaccine responses.
Frontiers in immunology   30 mars 2023
Humoral and cellular responses after a third dose of SARS-CoV-2 mRNA vaccine in patients with glomerular disease.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association   25 janvier 2023
Glomérulonéphrite Extra-Membraneuse
HAS Publications   12 décembre 2022